Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

COVID-19 as a whole is still a major national and international health concern. So far this year, there have been close to 45 ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the pandemic and all its variants through omicron in laboratory testing.

The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...

The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...

So far this year, Australia has recorded close to 45,000 new COVID-19 cases, while around 260 people are currently in ...

Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS ...

Pregnant women who contract SARS-CoV-2 may have a lower risk of developing Long COVID than matched non-pregnant women.